Trial · NCT01369888
Adverse events60
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 60
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Leukocytes (total WBC) | Blood and lymphatic system disorders | IL-15 Following Young TIL (0.25 mcg) | 1 | 1 | 1 |
| other | Leukocytes (total WBC) | Blood and lymphatic system disorders | IL-15 Following Young TIL (0.50 mcg) | 2 | 2 | 2 |
| other | Lymphopenia | Blood and lymphatic system disorders | IL-15 Following Young TIL (0.25 mcg) | 1 | 1 | 1 |
| other | Lymphopenia | Blood and lymphatic system disorders | IL-15 Following Young TIL (0.50 mcg) | 2 | 2 | 2 |
| other | Neutrophils/granulocytes (ANC/AGC) | Blood and lymphatic system disorders | IL-15 Following Young TIL (0.25 mcg) | 1 | 1 | 1 |
| other | Neutrophils/granulocytes (ANC/AGC) | Blood and lymphatic system disorders | IL-15 Following Young TIL (0.50 mcg) | 2 | 2 | 2 |
| other | Platelets | Blood and lymphatic system disorders | IL-15 Following Young TIL (0.25 mcg) | 1 | 1 | 1 |
| other | Platelets | Blood and lymphatic system disorders | IL-15 Following Young TIL (0.50 mcg) | 2 | 2 | 2 |
| other | Mucositis/stomatitis | Gastrointestinal disorders | IL-15 Following Young TIL (0.25 mcg) | 1 | 1 | 1 |
| other | Mucositis/stomatitis | Gastrointestinal disorders | IL-15 Following Young TIL (0.50 mcg) | 0 | 2 | |
| other | Infection | Infections and infestations | IL-15 Following Young TIL (0.25 mcg) | 1 | 1 | 1 |
| other | Infection | Infections and infestations | IL-15 Following Young TIL (0.50 mcg) | 0 | 2 | |
| other | Edema: limb | Blood and lymphatic system disorders | IL-15 Following Young TIL (0.25 mcg) | 1 | 1 | 1 |
| other | Edema: limb | Blood and lymphatic system disorders | IL-15 Following Young TIL (0.50 mcg) | 0 | 2 | |
| other | Cognitive disturbances | Nervous system disorders | IL-15 Following Young TIL (0.25 mcg) | 1 | 1 | 1 |
| other | Cognitive disturbances | Nervous system disorders | IL-15 Following Young TIL (0.50 mcg) | 0 | 2 | |
| other | Psychosis (hallucinations/delusions) | Nervous system disorders | IL-15 Following Young TIL (0.25 mcg) | 1 | 1 | 1 |
| other | Psychosis (hallucinations/delusions) | Nervous system disorders | IL-15 Following Young TIL (0.50 mcg) | 0 | 2 | |
| other | Pain | General disorders | IL-15 Following Young TIL (0.25 mcg) | 1 | 1 | 1 |
| other | Pain | General disorders | IL-15 Following Young TIL (0.50 mcg) | 0 | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01369888/events